Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-25-010174
Filing Date
2025-08-05
Accepted
2025-08-05 07:00:19
Documents
65
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 6-K aciu-20250630x6k.htm 6-K 25785
2 EX-99.1 aciu-20250630xex99d1.htm   iXBRL EX-99.1 997045
3 EX-99.2 aciu-20250630xex99d2.htm EX-99.2 280200
4 EX-99.3 aciu-20250630xex99d3.htm EX-99.3 204382
5 GRAPHIC aciu-20250630xex99d3001.jpg GRAPHIC 3076
  Complete submission text file 0001558370-25-010174.txt   5085653

Data Files

Seq Description Document Type Size
6 EX-101.SCH aciu-20250630.xsd EX-101.SCH 47168
7 EX-101.CAL aciu-20250630_cal.xml EX-101.CAL 47461
8 EX-101.DEF aciu-20250630_def.xml EX-101.DEF 111726
9 EX-101.LAB aciu-20250630_lab.xml EX-101.LAB 337879
10 EX-101.PRE aciu-20250630_pre.xml EX-101.PRE 231768
67 EXTRACTED XBRL INSTANCE DOCUMENT aciu-20250630xex99d1_htm.xml XML 930181
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)